Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinlu Yuan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Endocrinological Investigation|June 26, 2025
GDF15: An emerging disease target and biomarker of metabolic diseasesChenyun Yang, Huiling Chen, Xiaojing Huang, et al.
Experimental Eye Research|April 4, 2024
Retinal microcirculation: A window into systemic circulation and metabolic diseaseYue Yuan, Meiyuan Dong, Song Wen, et al.
Annals of Palliative Medicine|August 6, 2021
Association between plasma homocysteine levels and pancreatic islet beta-cell function in the patients with type 2 diabetes mellitus: a cross-sectional study from ChinaXinlu Yuan, Sheng Ding, Ligang Zhou, et al.
Journal of Translational Medicine|December 14, 2020
Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq dataXinlu Yuan, Jianjun Diao, Anqing Du, et al.
Bioscience Reports|September 10, 2020
Emodin ameliorates renal injury in BXSB mice by modulating TNF-α/ICAM-1Xinlu Yuan, Binbin Dai, Liyan Yang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 5, 2023
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic StrategyHuiling Chen, Xiaojing Huang, Meiyuan Dong, et al.
Journal of Translational Medicine|January 28, 2015
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesXinlu Yuan, Jie Wang, Xiaoyan Tang, et al.
Experimental Gerontology|September 5, 2024
Sarcopenia in cirrhosis: From pathophysiology to interventional therapyHuiling Chen, Chenyun Yang, Shijie Yan, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 27, 2023
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and DrugsXiaojing Huang, Huiling Chen, Song Wen, et al.
Lipids in Health and Disease|November 29, 2022
CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver diseaseXinlu Yuan, Yanyan Li, Song Wen, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Endocrinological Investigation|June 26, 2025
GDF15: An emerging disease target and biomarker of metabolic diseasesChenyun Yang, Huiling Chen, Xiaojing Huang, et al.
Experimental Eye Research|April 4, 2024
Retinal microcirculation: A window into systemic circulation and metabolic diseaseYue Yuan, Meiyuan Dong, Song Wen, et al.
Annals of Palliative Medicine|August 6, 2021
Association between plasma homocysteine levels and pancreatic islet beta-cell function in the patients with type 2 diabetes mellitus: a cross-sectional study from ChinaXinlu Yuan, Sheng Ding, Ligang Zhou, et al.
Journal of Translational Medicine|December 14, 2020
Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq dataXinlu Yuan, Jianjun Diao, Anqing Du, et al.
Bioscience Reports|September 10, 2020
Emodin ameliorates renal injury in BXSB mice by modulating TNF-α/ICAM-1Xinlu Yuan, Binbin Dai, Liyan Yang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 5, 2023
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic StrategyHuiling Chen, Xiaojing Huang, Meiyuan Dong, et al.
Journal of Translational Medicine|January 28, 2015
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesXinlu Yuan, Jie Wang, Xiaoyan Tang, et al.
Experimental Gerontology|September 5, 2024
Sarcopenia in cirrhosis: From pathophysiology to interventional therapyHuiling Chen, Chenyun Yang, Shijie Yan, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 27, 2023
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and DrugsXiaojing Huang, Huiling Chen, Song Wen, et al.
Lipids in Health and Disease|November 29, 2022
CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver diseaseXinlu Yuan, Yanyan Li, Song Wen, et al.
Pageof 4